• Mashup Score: 3

    We are grateful to these distinguished faculty who contributed to this collection: Kelley R.H. Branch, MD, FACC (Chair) Geoffrey D. Barnes, MD, MSc, FACC Marc P. Bonaca, MD, FACC Roxana Mehran, MD, FACC  Christian T. Ruff, MD

    Tweet Tweets with this article
    • Join expert faculty for quick-tip 📽️ on 👇 ✅ Aspirin Free Strategies ✅ Native Disease Dual Therapy ✅ Tips for Treating Patients w/ #cvPAD, more! Learn more from the 🆕 ACC 💻 Course on Antithrombotic Therapies For Coronary & Peripheral Atherosclerosis. https://t.co/JLmzOSVA3K https://t.co/tdlCovGtQ5

  • Mashup Score: 0

    It is estimated that peripheral arterial disease (PAD) affects over 12 million Americans.1 Critical limb ischemia (CLI), which is characterized by rest pain with or without tissue loss, is the most severe end of the PAD spectrum. About 11% of patients with PAD have CLI.2 Treatment for CLI requires aggressive revascularization strategies to minimize the risk of amputation. The BASIL trial,…

    Tweet Tweets with this article
    • The BEST-CLI trial offers new data to support initial surgery for patients with a suitable GSV conduit. However, more research is needed to validate surgery against optimal endovascular strategies. Learn more about the trial: https://t.co/95ikJIqQV2 #CardiologyMag #cvPAD https://t.co/hDtMcZEYlX